Invitrogen Adds BioProcessors’ SimCell High Throughput Automated Cell Culture Microbioreactor System For Process Development Services

Invitrogen Corporation (Nasdaq:IVGN) and BioProcessors Corporation today announced a technology collaboration in which Invitrogen will provide process development services utilizing BioProcessor’s SimCell Automated Management (SAM) robotic system. The installation of a SimCell unit in Invitrogen’s Grand Island facility is underway, with client projects offered through PD-Direct™ beginning this fall.

The SimCell system is a high throughput simulated scale-down bioreactor tool designed to run a higher number of experiments than previously feasible. “This technology enables data intensive approaches such as multivariate analyses to better engineer our cell culture media and enhance processes for our customers,” said Reg Joseph, Invitrogen’s Business Area Manager, BioProduction.

“BioProcessors’ SimCell technology was developed to meet the need for greater process development power,” said BioProcessors CEO Andrey Zarur. “We are excited about the pairing of Invitrogen’s process development expertise with the Design of Experiments capability enabled by the SimCell technology.”

Invitrogen and BioProcessors also announced that they will continue to collaborate on the development of high throughout cell culture applications for the SimCell platform and will look to expand MicroBioreactor™ technology into other areas of cell and tissue culture science.